PHP HEALTHCARE CORP
10-Q/A, 1997-04-03
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: INDUSTRIAL TECHNOLOGIES INC, SC 13D/A, 1997-04-03
Next: FCNB CORP, S-3DPOS, 1997-04-03




                 Securities and Exchange Commission
                        Washington, DC 20549
                          -----------------
                              FORM 10-Q
                           Amendment No. 4
(Mark One)
    
    [X] Quarterly Report Pursuant To Section 13 or  15(d)  of  the
Securities Exchange Act of 1934

For the quarterly period ended January 31, 1997.
    
    [  ]   Transition Report Pursuant to Section 13 or 15(d) of  the
Securities Exchange Act of 1934

For the transition period from _____________ to _______________

                   Commission file number 0-16235

                     PHP Healthcare Corporation
_____________________________________________________________________
(Exact name of registrant as specified in its charter)

Delaware                                              54-1023168
_____________________________________________________________________
(State or other jurisdiction of                   (IRS Employer
Incorporation or organization)                     Identification No.)
                                  
             11440 Commerce Park Drive, Reston, VA 20191
_____________________________________________________________________
(Address of principal executive offices)

Registrant's telephone number including area code

                           (703) 758-3600
_____________________________________________________________________


_____________________________________________________________________
Former name, former address and former fiscal year, if changed since
last report.

Indicate by check whether the registrant (i) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes [X]  No [ ].

Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.

Common stock, par value $.01 per share, outstanding as of January 31,
1997, 11,014,444 shares.
<PAGE>
                         AMENDMENT NO. 4
                                
     The undersigned registrant hereby files this Amendment No. 4
(the "Amendment") for the purposes of amending (i) Part I, Item 1
to include the report of Coopers & Lybrand L.L.P., dated March 31,
1997 and (ii) Part II, Item 6, to include the letter of Coopers &
Lybrand  L.L.P., dated April 3, 1997 regarding unaudited interim
financial statements.  The Amendment is set forth below.

                 PART I.  FINANCIAL INFORMATION
                                
Item 1.  Financial Statements


                 [Coopers & Lybrand Letterhead]

                
                Report of Independent Accountants
                                
To the Board of Directors of PHP Healthcare Corporation:

We have reviewed the accompanying Condensed Consolidated
Statements of Operations, Balance Sheets and Statements of Cash
Flows of PHP Healthcare Corporation and consolidated subsidiaries
as of January 31, 1997, and for the three month and nine month
periods ended January 31, 1997 and 1996, included on page 3
through 9 of this Form 10-Q/A-3.  These condensed consolidated
financial statements are the responsibility of the Company's
management.

We conducted our review in accordance with standards established
by the American Institute of Certified Public Accountants.   A
review of interim financial information consists principally of
applying analytical procedures to financial data and making
inquiries of persons responsible for financial and accounting
matters. It is substantially less in scope than an audit
conducted in accordance with generally accepted auditing
standards, the objective of which is the expression of an opinion
regarding the financial statements taken as a whole.
Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material
modifications that should be made to the accompanying condensed
consolidated financial statements for them to be in conformity
with generally accepted accounting principles.

The Company's original Form 10 Q dated March 17, 1997, has been
amended on Form 10 Q/A-3 dated March 31, 1997, to correct an
error in the calculation of earnings per share for the three
month and nine month periods ended January 31, 1997.

                              COOPERS & LYBRAND L.L.P.

Washington, D.C.
March 31, 1997





                                1
<PAGE>

                     PHP HEALTHCARE CORPORATION
                                  
           Condensed Consolidated Statements of Operations
    Three Months and Nine Months ended January 31, 1997 and 1996
                             (Unaudited)
               (In  thousands, except per share data)
<TABLE>
<CAPTION>
         

                                       Three Months      Nine Months
                                       1997    1996      1997    1996
                                       ----    ----      ----    ----
<S>                                  <C>     <C>      <C>      <C>                                               
Revenues............................ $50,434 $52,886  $162,280 $147,934

Direct costs........................  42,543  42,305   130,510  119,100
                                     _______ _______  ________ ________
     Gross profit...................   7,891  10,581    31,770   28,834

General and administrative expenses.   8,165   7,039    22,584   20,971
Reserve for Medicaid receivables       
  (note 2)..........................   9,822     ---     9,822      ---
Former chairman retirement package     
  (note 4)..........................   2,275     ---     2,275      ---
Restructuring charges (note 5)......   2,550     ---     2,550      ---
                                     _______ _______  ________ ________
     Operating income (loss)........ (14,921)  3,542    (5,461)   7,863

Other income (expense):
   Interest expense.................  (1,360)   (979)   (4,128)  (2,076)
   Interest income..................     470     482     1,679      885
   Miscellaneous income (expense)...     (34)    (20)      (67)      49
   Gain on sale of subsidiary stock.     ---   2,247       ---    2,247
   Minority interest in earnings of 
     subsidiaries...................     (78)    ---      (316)     ---
                                     _______ _______  ________ ________
     Earnings (loss) before income 
     taxes.......................... (15,923)  5,272    (8,293)   8,968

Income tax expense (benefit)........  (6,021)  1,112    (3,151)   2,554
                                     _______ _______  ________ ________
      Net earnings (loss)........... $(9,902)$ 4,160   $(5,142) $ 6,414
                                     ======= =======  ======== ========
Net earnings (loss) per share....... $ (0.90)$  0.31  $  (0.47)$   0.48
                                     ======= =======  ======== ========
Weighted average number of common 
  and common equivalent shares 
  outstanding......................   11,005  13,603    10,986   13,280
                                     ======= =======  ======== ========
</TABLE>        

See accompanying notes to condensed consolidated financial statements.




                                  
                                   2
<PAGE>
                     PHP HEALTHCARE CORPORATION
                                  
                Condensed Consolidated Balance Sheets
              As of January 31, 1997 and April 30, 1996
                  (In thousands, except share data)

<TABLE>       
<CAPTION>         

                                          January 31   April 30,
                                             1997        1996
                                             ----        ----
<S>                                     <C>          <C>         
ASSETS                                    (Unaudited)
Current assets:
 Cash and cash equivalents.............  $ 29,148     $ 48,647
 Accounts receivable, net (note 2).....    47,924       46,578
 Pharmaceutical and medical supplies...       785        1,039
 Receivables from officers.............     4,101        3,263
 Other current assets..................     6,395        4,048
                                         ________     ________
     Total current assets..............    88,353      103,575
Property and equipment, net............    27,595       22,685
Excess of cost over fair value of 
  assets acquired, net of
  accumulated amortization 
  of $962 in January and $810 in April.     2,959        2,942
Deferred income taxes..................     1,321          543
Receivables from officers, net.........     1,072        1,072
Other assets...........................     5,440        4,538
                                         ________     ________
                                         $126,740     $135,355
                                         ========     ========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
   Current maturities of notes payable       
     - other...........................       574          545
   Accounts payable....................     8,046        9,520
   Claims payable - medical services...     4,646        9,154
   Accrued salaries and benefits    
     (notes 4 and 5)...................    15,020       11,228
   Deferred income taxes...............     1,322        4,322
   Billings in excess of costs.........     1,105          244
                                         ________     ________
      Total current liabilities            30,713       35,013
Notes payable - other, net of current 
  maturities...........................     1,486        1,921
Convertible subordinated debentures....    65,986       65,608
Deferred gain on sale of building......       938        1,002
Other liabilities......................       696          519
                                         ________     ________
      Total liabilities                    99,819      104,063
                                         ________     ________

Minority interest......................       862          545
                                         ________     ________
Stockholders' equity:
   Preferred stock, $.01 par value, 
     500,000 shares authorized, none
     issued............................       ---         ---
   Common stock, $.01 par value, 
     25,000,000 shares authorized,
     14,272,929 shares issued in 
     January and 14,203,987 shares in
     April.............................       143          142
   Additional paid-in-capital..........    30,982       30,529
   Note receivable from sale of stock..      (900)        (900)
   Retained earnings...................     2,406        7,548
   Treasury stock, 3,258,485 common 
     shares, at cost...................    (6,572)      (6,572)
                                          ________     ________
      Total stockholders' equity            26,059       30,747
Contingencies (note 6)                    ________     ________
                                          $126,740     $135,355
                                          ========     ========
</TABLE>                                          
See accompanying notes to condensed consolidated financial statements.


                                  3
<PAGE>
                     PHP HEALTHCARE CORPORATION
                                  
           Condensed Consolidated Statements of Cash Flows
    Three Months and Nine Months Ended January 31, 1997 and 1996
                             (Unaudited)
                           (In thousands)
                                  
<TABLE>      
<CAPTION>         
                                  
                                       Three Months      Nine Months
                                       1997     1996     1997     1996
                                       ----     ----     ----     ----
<S>                                  <C>       <C>     <C>       <C>               
Cash flows from operating activities:
 Net earnings (loss).................$ (9,902) $ 4,160 $ (5,142) $ 6,414
 Adjustments to reconcile net 
   earnings (loss) to net cash
   used in operating activities:
    Gain on sale of subsidiary stock.      ---  (2,247)     ---   (2,247)
    Minority interest in earnings 
      of subsidiaries................       78     ---      316      ---
    Depreciation and amortization....    1,136   1,188    3,712    3,235
    Increase (decrease) in deferred 
      income taxes...................   (3,778)    440    (3,778)  1,882
   Other items, net..................      (21)    (21)      (64)    (61)
 Changes in operating assets and 
   liabilities:
   Decrease (increase) in accounts 
     receivable, net.................   11,878  (7,776)   (1,346)(13,499)
   Decrease in pharmaceutical and 
     medical supplies................      177       5       254       99
   Decrease (increase) in other 
     current assets..................    (687)    431    (2,348)    (632)
   Increase in other assets..........    (430)   (195)     (996)    (623)
   Increase (decrease) in accounts 
     payable.........................  (3,499) (1,904)   (1,473)     350
   Increase (decrease) in claims 
     payable.........................  (1,219) (1,794)   (4,508)     675
   Increase in accrued salaries and 
     benefits........................   1,802     549     3,792    1,999
   Increase (decrease) in billings 
     in excess of costs..............     934    (583)      861      188
   Decrease in income taxes payable..  (2,845)    ---       ---      ---
   Increase (decrease) in other  
     liabilities.....................      89    (196)      177      201
                                      _______  _______  _______  _______
      Net cash used in operating 
      activities.....................  (6,287) (7,943)  (10,543)  (2,019)
                                      _______  _______  _______  _______
Cash flows from investing activities:
   Acquisition of property and 
    equipment........................  (2,041) (1,112)   (8,166)  (2,445)
   Sale of subsidiary stock..........    ---    3,000      ---     3,000
                                      _______  _______   _______  _______
    Net cash provided by (used in) 
      investing activities...........  (2,041)   1,888   (8,166)     555
                                      _______  _______   _______  _______
Cash flows from financing activities:
 Proceeds from issuance of convertible
   subordinated debentures...........     ---   65,831      ---   65,831
 Net repayments under revolving 
   promissory notes..................     ---  (17,815)     ---  (20,546)
 Borrowing on notes payable..........     ---      ---      ---    1,918
 Repayments on notes payable.........    (138)  (3,732)    (406)  (5,329)
 Receivables from officers...........       3      (81)    (838)    (259)
 Proceeds from exercise of stock options   97       216     454      328
                                       _______  _______   _______  _______
    Net cash provided by (used in) 
     financing activities............     (38)   44,419    (790)   41,943
                                       _______  _______   _______  _______
    Net increase (decrease) 
     in cash and cash equivalents....   (8,366)  38,364  (19,499)  40,479
Cash and cash equivalents, beginning 
 of period...........................   37,514    3,293   48,647    1,178
                                       _______  _______   _______  _______
Cash and cash equivalents, end of 
 period..............................  $29,148  $41,657  $29,148  $41,657
                                       =======  =======   =======  =======
        
</TABLE>
See accompanying notes to condensed consolidated financial statements.


                                  4
<PAGE>

                     PHP HEALTHCARE CORPORATION
                                  
        Notes to Condensed Consolidated Financial Statements
                                  
                          January 31, 1997
                             (Unaudited)

(1)  Summary of Significant Accounting Policies

     (a)  Basis of Presentation
     In the opinion of the Company, the interim condensed
consolidated financial statements include all adjustments, consisting
of only normal recurring adjustments, necessary for a fair
presentation of the results for the interim periods. Certain
information and footnote disclosures normally included in financial
statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted. The interim condensed
consolidated financial statements should be read in conjunction with
the Company's April 30, 1996 and 1995 audited consolidated financial
statements. The year-end condensed consolidated balance sheet data
was derived from audited consolidated financial statements but does
not include all disclosures required by generally accepted accounting
principles.  The interim operating results are not necessarily
indicative of the operating results for the full fiscal year. Certain
amounts in the fiscal year 1996 condensed consolidated financial
statements have been reclassified to conform with the fiscal year
1997 presentation.

     (b) New Accounting Pronouncement
     In October 1995, the Financial Accounting Standards Board (FASB)
issued SFAS No. 123, "Accounting for Stock-Based Compensation".  As
permitted by the Standard, the Company does not intend to adopt the
provisions for recognizing compensation expense for grants to
employees of stock, stock options, and other equity instruments based
on a new fair value method.  Accordingly, this Standard is not
expected to have any impact on amounts recorded in the Company's
consolidated financial statements.  However, beginning with fiscal
year 1997, the Standard will require the Company to disclose
additional information in the footnotes to its annual consolidated
financial statements, including pro forma net income and earnings per
share under the new fair value method.

(2)  Accounts Receivable

     D.C. Chartered Health Plan, Inc. ("CHP"), a wholly-owned health
maintenance organization, earns substantially all of its revenue as a
prepaid Medicaid contractor with the D.C. Department of Human
Services (DCDHS) providing health care services to Medicaid
recipients in the District of Columbia.  The Medicaid program is
jointly funded by the District of Columbia and the Health Care
Finance Administration (HCFA) of the Department of Health and Human
Services (HHS).

     CHP receives interim payments on an estimated basis with a final
settlement occurring at the end of the contract period for the
difference between amounts earned and the interim payments.  The
final settlement process with DCDHS and HCFA is subject to defined
upper payment limits and requires an audit of CHP's activities.  Due
to the unique nature of these contracts, DCDHS has not undergone a
final settlement process for this type of contract.

                                  5
<PAGE>
                    PHP HEALTHCARE CORPORATION
                                  
   Notes to Condensed Consolidated Financial Statements (cont'd.)


     In April 1996, the U.S. Government enacted a law, the effect of
which requires the Company's contracts with DCDHS to be settled
retroactively on a capitated-rate-per-enrollee basis.  Prior to the
enactment of the law, the terms of the contracts provided that the
final settlements would be on a non-risk basis, calculated in part on
a cost-based methodology.

     The Company believes that a final settlement of these contracts
for the periods 1992 through 1996 under the method prescribed by the 
new law results in amounts due the Company in excess of the $17.6 
million and $14.4 million in receivables recorded at October 31, 1996 
and April 30, 1996, respectively, which amounts have been consistently 
calculated based upon the Company's conservative interpretation of 
the methods in effect prior to the enactment of the new law.

     For several years the Company engaged in on-going good faith
discussions and negotiations with the District regarding amounts due for 
the 1992 and 1994 contract years.  That process ultimately resulted 
in an agreement to settle these amounts due the Company for 
$18.9 million.  It is now evident to the Company, however, through 
recent comments in the local press, that payment has been blocked.  
Consequently, in light of the clearly prolonged timeframe to resolve 
these issues, the Company has determined to recognize reserves of 
$9.8 million against its Medicaid receivables from the District of 
Columbia, principally relating to services provided during the 1992 
to 1994 contract years.

        The Company remains committed to pursuing its contractual 
rights for the amounts it is due from the District.

(3) Notes Payable - Bank

     The Company has extended the term of its primary banking
facility, a $12.2 million revolving promissory note, until May 1997.
This credit facility, previously due to expire in November 1996, was
extended at principally the same terms and conditions.

     As a result of the several one-time charges against earnings
recorded during the third quarter of fiscal year 1997, the Company
was not in compliance with certain of the various financial covenants
in the borrowing agreement with its primary bank as of January 31,
1997.  The Company is in the process of obtaining a waiver for all
conditions of noncompliance.  At January 31, 1997, the Company had no
borrowings under the agreement.

                                  6
<PAGE>
                     PHP HEALTHCARE CORPORATION
                                  
   Notes to Condensed Consolidated Financial Statements (cont'd.)


(4)  Retirement of Former Chairman

     On January 31, 1997, the Company's Founder, Chairman and Chief
Executive Officer, Charles H. Robbins, retired.  The Board of
Directors provided Mr. Robbins a retirement agreement that included a
one-time $2 million payment and a payment of $275,000 related to a
one-year noncompetition agreement.  The agreement further requires
Mr. Robbins to repay (by April 30, 1997) all outstanding notes
receivable and accrued interest due the Company within the Senior
Executive Loan Program and notes receivable related to certain life
insurance policies.  Under the agreement, Mr. Robbins has the right
(through April 30, 1997) to require the Company to purchase up to
200,000 shares of his stock in the Company at the then current market
price.  The agreement contains additional clauses which include,
among other things, a "standstill" provision and restrictions on the
timing of any dispositions of Mr. Robbins' holdings in the Company.

     For the quarter ended January 31, 1997, the Company recognized
$2.275 million in expense related to the retirement agreement.

(5)  Restructuring Charges

     During the third quarter ended January 31, 1997, the Company
incurred restructuring charges of $2.55 million.  Within a broad
restructuring effort, this charge resulted from two specific
decisions made by the Board of Directors.

     In late November 1996, the Company made the strategic decision
to terminate its long-term care line of business, an unprofitable 
operation, in the Government Managed Care Services division.  
The Company has recognized a net loss of $1.8 million related to the 
restructuring for the termination of this line of business.  

     Effective January 31, 1997, the Company made the
strategic decision to terminate the Company's facilities development
and maintenance function operated out of the corporate offices
through the Company's wholly owned subsidiary, Sterling Communities
Corporation.  Future building and facilities management needs will be 
fulfilled through outsourced vendor relationships.  The Company incurred a
restructuring charge of $750,000 for severance and other termination
costs associated with the elimination of this function.

                                  7
<PAGE>
                     PHP HEALTHCARE CORPORATION
                                  
   Notes to Condensed Consolidated Financial Statements (cont'd.)


(6)  Contingencies

     The Company is a defendant in various legal actions.  The
principal actions allege or involve claims under contractual
arrangements, employment matters, and medical malpractice with an
estimated possible range of loss between approximately $115,000 and
$1.1 million in excess of insurance coverage.  The Company has not
recorded any reserves related to these actions at January 31, 1997.
In the opinion of management, after consultation with legal counsel,
the possible additional losses related to these actions, if any, will
not result in any material adverse effect on the Company's
consolidated financial position, results of operations, or cash
flows. The Company maintains medical malpractice insurance coverage
which provides for reimbursement of any claim amounts in excess of
$250,000 and $50,000 per incident for government and commercial
business, respectively.

(7)  Subsequent Event - Acquisition of New Jersey Family Healthcare
Centers

     On February 28, 1997, the Company purchased 10 healthcare
centers from Blue Cross and Blue Shield of New Jersey (BCBSNJ) for
approximately $35 million cash, 90,000 shares of the Company's
treasury stock, and other consideration.  Concurrently, the Company
sold the 6 owned health center buildings to a subsidiary of G&L Realty 
Corporation for $22.5 million.  Based in Beverly Hills, California, 
G&L Realty, which is traded on the New York Stock Exchange, is a 
healthcare real estate investment trust specializing in medical office 
buildings and other healthcare facilities.  The Company has a minority 
interest in the subsidiary and has entered into 25-year lease
commitments for these same buildings.  The Company has also advanced 
approximately $18 million as a short-term secured loan to the subsidiary 
until permanent financing is obtained.

     The acquisition will be accounted for using the purchase method
of accounting and accordingly, the purchase price will be allocated
to the acquired tangible and identifiable intangible assets and
liabilities based on their respective fair values.  Final accounting
for this acquisition is still subject to various appraisals which
must be undertaken to assign values to the tangible and intangible
assets acquired.








                                  8
<PAGE>

                   PART II.  OTHER INFORMATION
                                
                                
Item 6.  Exhibits and Reports on Form 8-K

a)   Exhibits

       3.1    Articles of Incorporation of PHP Healthcare Corporation*

       3.2    Bylaws of PHP Healthcare Corporation*

      11.0    Statement re:  Computation of per share earnings for
              the three months and nine months ended January 31, 1997 
              and 1996*

      15.1    Letter of Coopers & Lybrand L.L.P. regarding Unaudited
              Interim Financial Statements


              










_______________________
*     Previously filed as an Exhibit to the Company's Form  10-Q,
Amendment   No.  3,  filed  with  the  Securities  and   Exchange
Commission on March 31, 1997.
                               
                               9
<PAGE>


                     PHP HEALTHCARE CORPORATION
                                  
                             SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf
by the undersigned duly authorized.

                              PHP HEALTHCARE CORPORATION
                                   (Registrant)



                              By:   /s/ Anthony M. Picini
                                   ANTHONY M. PICINI
                                   Executive Vice President and
                                   Chief Financial Officer





Date:  April 3, 1997
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                  
                                 10
<PAGE>

                   
                   
                   PHP HEALTHCARE CORPORATION
                                
                          EXHIBIT INDEX
                                
                                
Exhibit         Item

  3.1           Articles of Incorporation of PHP Healthcare Corporation*

  3.2           Bylaws of PHP Healthcare Corporation*

 11.0           Statement re:  Computation of per share earnings for
                the three months and nine months ended January 31, 1997 
                and 1996*

 15.1           Letter of Coopers & Lybrand L.L.P. regarding Unaudited
                Interim Financial Statements


















_______________________
*     Previously filed as an Exhibit to the Company's Form  10-Q,
Amendment   No.  3,  filed  with  the  Securities  and   Exchange
Commission on March 31, 1997.
                               
                                11


                                                     EXHIBIT 15.1
                                                                 
                       [Coopers & Lybrand Letterhead]



                                                                 
                                                                 
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC  20549

Re:  PHP Healthcare Corporation, Registrations on Form S-3 and on
     Form S-8

We are aware that our report dated March 31, 1997 on our review
of interim financial information of PHP Healthcare Corporation
and consolidated subsidiaries as of January 31, 1997 and for the
three month and nine month periods ended January 31, 1997 and
1996, and included in the Company's quarterly report on Form 10-Q
as amended on Form 10-Q/A-3 and Form 10-Q/A-4 for the quarter
then ended, is incorporated by reference in Registration
Statement No. 33-301101 on Form S-3 and in Registration Statement
No. 33-41577 on Form S-8.  Pursuant to Rule 436(c) under the
Securities Act of 1933, this report should not be considered a
part of the prospectus and registration statement prepared or
certified by us within the meaning of Section 7 and 11 of that
Act.

                                   COOPERS & LYBRAND L.L.P.

Washington, D.C.
April 3, 1997


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission